FC
DNMR

Fairpointe Capital’s Danimer Scientific, Inc. DNMR Stock Holding History

Fairpointe Capital’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$755K Buy
+500
New +$812K 1.14% 28

Other funds holding DNMR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Fairpointe Capital's DNMR Position: Q1 2021 in Review

Fairpointe Capital opened a new position in Danimer Scientific, Inc. (DNMR) in Q1 2021: 500 shares worth $755K. The stake represents 1.14% of the portfolio and ranks #28 among its holdings.

206 funds tracked by Wall St. Rank hold DNMR as of Q1 2021.

  • Fairpointe Capital held 500 shares of Danimer Scientific, Inc. worth $755K as of Q1 2021.
  • Danimer Scientific, Inc. was a new Fairpointe Capital position in Q1 2021.
  • Danimer Scientific, Inc. made up 1.14% of Fairpointe Capital's portfolio in Q1 2021, its #28 holding.
  • 206 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q1 2021.

Based on Fairpointe Capital's 13F filing for Q1 2021, filed 13 May 2021.